OMNISPIRANT LIMITED
Desconocido
INSPIRE: Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delive...
OMNISPIRANT LIMITED
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-TOOL-06
Lung cancer (LC) treatments have advanced in recent years with the advent of genetic profiling and immunotherapy. However, LC is a complex h...
2022-05-24 - 2025-05-31 | Financiado
2022-05-24 - 2025-05-31 | Financiado
ReSpire: Respirable Advanced Therapeutics for Cystic Fibrosis other Lung Diseases
OMNISPIRANT LIMITED
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Via the SME Instrument OmniSpirant Ltd will mature its stem cell exosome-packaged gene therapy with lung mucus
penetration properties which...
2019-01-28 - 2019-07-31 | Financiado
2019-01-28 - 2019-07-31 | Financiado
* No se disponen de datos de la empresa actual.